Barclays Boosts Hikma Pharmaceuticals (OTCMKTS:HKMPF) Price

Hikma Pharmaceuticals (OTCMKTS:HKMPF – Free Report) had its price objective increased by Barclays from GBX 1,700 ($21.87) to GBX 1,800 ($23.16) in a research note issued to investors on Wednesday morning, FlyOnTheWall reports. Separately, Royal Bank of Canada increased their price objective on Hikma Pharmaceuticals from GBX 1,950 ($25.09) to GBX 2,050 ($26.37) in a […]

Related Keywords

Canada , United States , America , , Royal Bank , Analyst Recommendations For Hikma Pharmaceuticals , Hikma Pharmaceuticals Price Performance , Barclays , News Ratings For Hikma Pharmaceuticals Daily , Hikma Pharmaceuticals , Free Report , Moderate Buy , Get Free Report , North America , Middle East , North Africa , Hikma Pharmaceuticals Daily , Otcmkts Hkmpf , Hkmpf , Medical , Boost Price Target , Barclays Plc ,